7 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Terminated 7 |
Follow Alcohol Dependence: new trials by email Literature Review of Alcohol Dependence trials Research Report on Alcohol Dependence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Valproate on Ethanol Withdrawal Valproate, Lorazepam - Alcohol Dependence, Alcohol Withdrawal Syndrome | Phase 4 | Terminated | CAMC Health System | 3 | 2017-07-11 | 2026-08-18 |
| Treatment for Alcohol Dependence With Gabapentin Gabapentin 2g/day divided in two doses for 24 weeks, Placebo 2g/day divided in two doses for 24 weeks - Alcohol Dependence | Phase 4 | Terminated | Dayanand Medical College and Hospital | 25 | 2016-06-01 | 2020-02-13 |
| Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care Selincro® 18 mg with continuous psychosocial support: Cohort A, Initial psychosocial support: Cohort B - Alcohol Dependence | Phase 4 | Terminated | H. Lundbeck A/S | 378 | 2014-08-01 | 2017-02-28 |
| Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers Naltrexone, Control - Alcohol Dependence | Phase 4 | Terminated | Centre for Addiction and Mental Health | 2 | 2012-08-01 | 2014-04-02 |
| Pilot Study of Depot NTX in Homeless Veterans Depot naltrexone, Oral Naltrexone - Alcohol Dependence | Phase 4 | Terminated | US Department of Veterans Affairs | 7 | 2010-08-01 | 2014-07-17 |
| Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial Injectable Naltrexone - Alcohol Dependence, Veterans | Phase 4 | Terminated | State University of New York - Upstate Medical University | 20 | 2006-10-01 | 2011-10-24 |
| Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees Acamprosate - Alcohol Dependence | Phase 4 | Terminated | Virginia Commonwealth University | 26 | 2005-06-01 | 2016-05-11 |
Alcoholism (7) · Wounds and Injuries (1)
Alcohol-Related Disorders (7) · Chemically-Induced Disorders (7) · Mental Disorders (7) · Substance-Related Disorders (7)
Naltrexone (2) · Acamprosate (1) · Gabapentin (1) · Lorazepam (1) · Starch (1) · Valproic Acid (1) · nalmefene (1) · vivitrol (1)
CAMC Health System (1) · Centre for Addiction and Mental Health (1) · Dayanand Medical College and Hospital (1) · H. Lundbeck A/S (1) · State University of New York - Upstate Medical University (1) · US Department of Veterans Affairs (1) · Virginia Commonwealth University (1)
United States (4) · Canada (1) · France (1) · Germany (1) · India (1) · Spain (1) · United Kingdom (1)
Audis Bethea, PharmD, BCPS (1) · Bernard Le Foll, MD, PhD (1) · Michael F. Weaver, MD (1) · Peter D Friedmann, MD MPH (1) · Sandeep S Sidhu, DM (1) · Steven L Batki, M.D. (1)
PMID 16300039, PMID 18614026, PMID 18819759, PMID 19560604, PMID 23577900, PMID 24190578, PMID 8628042
K23AA000222 (1)